Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction

Liver International

Volumn 35, Issue 10, 2015, Pages 2294-2300

  Lai, Jennifer C ^a   Bikle, Daniel D ^a,b   Lizaola, Blanca ^c   Hayssen, Hilary ^a   Terrault, Norah A ^a   Schwartz, Janice B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Albumin; Free hormone hypothesis; Metabolic bone disease; Parathyroid hormone; Vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; ALBUMINOID; BIOLOGICAL MARKER; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PROSPECTIVE STUDY; VITAMIN SUPPLEMENTATION; BLOOD; BONE REMODELING; DIETARY SUPPLEMENT; MIDDLE AGED;

ALBUMINS; ALKALINE PHOSPHATASE; BIOMARKERS; BONE REMODELING; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84942374718     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12819     Document Type: Article

References (25)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
2. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-20.
3. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2009; 55: 2624-8.
4. Lim LY, Chalasani N. Vitamin D deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep 2011; 14: 67-73.
5. Hepner GW, Roginsky M, Moo HF. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976; 21: 527-32.
6. Crawford BA, Labio ED, Strasser SI, McCaughan GW. Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 689-99.
7. Gallego-Rojo FJ, Gonzalez-Calvin JL, Muñoz-Torres M, et al. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28: 695-9.
8. Carey EJ, Balan V, Kremers WK, Eileen HJ. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl 2003; 9: 1166-73.
9. Diamond T, Stiel D, Mason R, et al. Serum vitamin d metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 1989; 69: 1234-9.
10. Matloff DS, Kaplan MM, Neer RM, et al. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 1982; 83: 97-102.
11. Herlong HF, Recker RR, Maddrey WC. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 1982; 83: 103-8.
12. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994; 89: 47-50.
13. Collier J. Bone disorders in chronic liver disease. Hepatology 2007; 46: 1271-8.
14. Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, et al. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010; 4: 634-40.
15. Crawford BAL, Kam C, Donaghy AJ, McCaughan GW. The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 2003; 14: 987-94.
16. Bikle DD, Gee E, Halloran B, et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986; 63: 954-94.
17. Bikle DD, Gee E. Free, and not total, 1, 25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 1989; 124: 649-54.
18. Schwartz JB, Lai J, Lizaola B, et al. A comparison of direct and calculated free 25(OH) Vitamin D levels in clinical populations. J Clin Endocrinol Metab 2014; 99: 1631-7.
19. American Gastroenterological Association, Pressman A. American gastroenterological association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 2003; 125: 937-40.
20. Malham M. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011; 17: 922.
21. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.
22. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-43.
23. Guichelaar MMJ, Malinchoc M, Sibonga JD, Clarke BL, Eileen HJ. Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 2003; 18: 2190-9.
24. Giouleme OI, Vyzantiadis TA, Nikolaidis NL, et al. Pathogenesis of osteoporosis in liver cirrhosis. Hepatogastroenterology 2006; 53: 938-43.
25. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.